Cuddalore-based integrated fluorochemicals manufacturer making hydrofluoric acid, sulphuric acid and specialty fluoride derivatives.
Price
Market Cap
Sector
Commodities
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves | 55 | 73 | 124 | 174 | 220 | 302 | 330 | 363 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 41 | 31 | 93 |
| Other Liabilities | 24 | 37 | 49 | 68 | 71 | 73 | 91 | 62 |
| Total Liabilities | 89 | 120 | 182 | 252 | 301 | 426 | 462 | 528 |
| AssetsFixed Assets | 33 | 40 | 40 | 55 | 61 | 168 | 197 | 212 |
| CWIP | 6 | 3 | 12 | 6 | 29 | 8 | 22 | 29 |
| Investments | 1 | 23 | 42 | 67 | 67 | 9 | 9 | 19 |
| Other Assets | 49 | 55 | 88 | 124 | 145 | 242 | 234 | 269 |
| Total Assets | 89 | 120 | 182 | 252 | 301 | 426 | 462 | 528 |
| Line item | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | 37 | 22 | 37 | 44 | 43 | 34 | 33 | 43 |
| Cash from Investing | -3 | -9 | -34 | -35 | -40 | -30 | -42 | -91 |
| Cash from Financing | -34 | -12 | -1 | -5 | -6 | -7 | 32 | 38 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — | — |
| Free Cash Flow | 35 | 11 | 29 | 29 | 28 | -2 | -64 | -39 |
| FCF Margin | — | — | — | — | — | — | — | — |
The Earnings Per Share over the last 12 months.
Your assumption of the company's expected yearly EPS growth (e.g., 6 for 6%).
Pre-filled with the lower of median (74.9×) and current (68.1×) PE — the conservative anchor.
The annualized return you aim to achieve. We solve for the price that delivers it, then compare to today's price.
At 11.1% growth and a 68× exit, ₹2272 only delivers your return if you pay ₹1,660. The price is currently baking in 18% growth.
EPS grows 11.1%/yr for 5 years, then fades to 6% over 2, exits at 68×.
| Year | Growth | EPS (₹) |
|---|---|---|
| FY27 | 11.1% | 37.05 |
| FY28 | 11.1% | 41.16 |
| FY29 | 11.1% | 45.73 |
| FY30 | 11.1% | 50.81 |
| FY31 | 11.1% | 56.45 |
| FY32 | 8.5% ·fade | 61.28 |
| FY33 | 6.0% ·fade | 64.95 |
Methodology: we discount normalized net profit as a proxy for owner earnings (an earnings-power approximation — not full free cash flow). Terminal growth is capped at 6% (≈ nominal GDP) regardless of the required return. This is an analytical tool, not investment advice.
Guides on how to read this kind of business and the numbers that matter.